Personal information

Verified email domains

Metabolomics, Lipidomics, Drug Discovery
Netherlands

Biography

Martin studied pharmacy in Heidelberg and Munich. He is Associate Professor and head of the Metabolomics group at the Center for Proteomics and Metabolomics at the Leiden University Medical Center (LUMC). He holds a PhD in Pharmaceutical Chemistry obtained from the Ludwig-Maximilians-University in Munich (Germany) under the supervision of Prof. Franz Bracher. With a postdoctoral fellowship (DAAD stipend), he joined the group of Prof. Hubertus Irth at the VU University Amsterdam where he later became Assistant Professor and head of the Bioanalysis group. Following a research stay in the laboratory of Prof. Charles Serhan at Harvard Medical School, he moved to the LUMC where he today heads the Metabolomics group. He was a visiting professor at the Metabolomics center of the Scripps institute (La Jolla, CA, USA) headed by Prof. Gary Siuzdak. He is editor of the book “Clinical Metabolomics” (Springer) (1st and 2nd edition) and edited the first metabolomics teaching book aimed at undergraduate students and instructors (doi.10.1007/978-3-031-44256-8). Martin was a permanent committee member of the inter-disciplinary panel of the FWO and served in several EU committees, e.g. INFECT-ERA. He is a consultant for metabolomics and lipidomics. His main interests lie in clinical, translational and fundamental disease-related research, using metabolomics-based approaches and notably lipidomics. Martin has published more than 200 peer-reviewed articles, books and is an inventor on two patents.

Activities

Employment (3)

Leids Universitair Medisch Centrum: Leiden, Zuid-Holland, NL

2011-07 to present | Assoc. Prof. (Center for Proteomics and Metabolomics)
Employment
Source: Self-asserted source
Martin Giera

Vrije Universiteit Amsterdam: Amsterdam, Noord-Holland, NL

2009-07 to 2011-07 | Ass. Prof.
Employment
Source: Self-asserted source
Martin Giera

Vrije Universiteit Amsterdam: Amsterdam, NL

2008-07 to 2009-07 | Posdoc
Employment
Source: Self-asserted source
Martin Giera

Education and qualifications (1)

Ludwig-Maximilians-Universitat Munchen: Munchen, Bayern, DE

2005-02 to 2008-07 | PhD (Pharmazie)
Education
Source: Self-asserted source
Martin Giera

Professional activities (1)

Fonds Wetenschappelijk Onderzoek Vlaanderen: Brussel, BE

2019-08-01 to 2023-01-01 (Interdisciplinary)
Service
Source: Self-asserted source
Martin Giera

Funding (14)

Ethical Eggs

2025 to 2029 | Grant
Toegepaste en Technische Wetenschappen, NWO (The Hague, NL)
Source: Self-asserted source
Martin Giera

DHCR24 inhibitors as novel treatments for non-alcoholic steatohepatitis

2024 to 2024 | Grant
NWO (The Hague, NL)
Source: Self-asserted source
Martin Giera

Glycan trigger

2023 to 2027 | Grant
H2020 Marie Skłodowska-Curie Actions (Brussels, BE)
Source: Self-asserted source
Martin Giera

Targeting brain cholesterol biosynthesis as a potential novel MS therapy

2023 to 2024 | Grant
Stichting MS Research (Voorschoten, NL)
Source: Self-asserted source
Martin Giera

reNEW

2022 to 2032 | Grant
Novo Nordisk Foundation (Copenhagen, DK)
Part of GRANT_NUMBER:

NNF21CC0073729

Source: Self-asserted source
Martin Giera

The Neurolipid Atlas part 2

2022 to 2026 | Grant
Chan Zuckerberg Initiative (United States) (Redwood City, US)
Source: Self-asserted source
Martin Giera

OMICSER

2022 to 2024-11 | Grant
Chan Zuckerberg Initiative (United States) (Redwood City, US)
Source: Self-asserted source
Martin Giera

The Neurolipid Atlas

2021-01 to 2023-08 | Grant
Chan Zuckerberg Initiative (CA, CA, US)
Source: Self-asserted source
Martin Giera

ArthritisHeal

2019-03 to 2023 | Grant
European Commission (Brussel, BE)
GRANT_NUMBER:

812890

Source: Self-asserted source
Martin Giera

XOMICS

2019 to 2029 | Grant
NWO (The Hague, NL)
Source: Self-asserted source
Martin Giera

Dehydrocholesterol reductase 24 a possible target for the treatment of nonalcoholic steatohepatitis?

2018 to 2019 | Grant
ZonMw (Amsterdam, Not Specified, NL)
Source: Self-asserted source
Martin Giera

Determining the underappreciated role of lipid metabolism in MSC-mediated immunomodulation.

2018 to 2019 | Grant
ZonMw (Amsterdam, Not Specified, NL)
Source: Self-asserted source
Martin Giera

Analysis of omega 3- and 6 fatty acid metabolism in cigarette smoke-induced lung inflammation

2015 to 2016 | Grant
ZonMw (Amsterdam, Not Specified, NL)
Source: Self-asserted source
Martin Giera

In-depth mapping of the species-lipidome in the kefir community

2015 to 2016 | Grant
ZonMw (Amsterdam, Not Specified, NL)
Source: Self-asserted source
Martin Giera

Peer review (71 reviews for 31 publications/grants)

Review activity for ACS chemical biology. (1)
Review activity for Analytical chemistry. (13)
Review activity for Arthritis research & therapy (1)
Review activity for Arthritis research & therapy. (1)
Review activity for British journal of pharmacology. (2)
Review activity for Cell reports. (2)
Review activity for Cellular & Molecular Biology Letters. (2)
Review activity for Chemical reviews. (2)
Review activity for Chirality. (2)
Review activity for Chromatographia. (3)
Review activity for Clinica chimica acta. (1)
Review activity for Drug development research. (2)
Review activity for Drug discovery today. (1)
Review activity for FEBS letters. (1)
Review activity for Journal of internal medicine. (1)
Review activity for Journal of medicinal chemistry. (2)
Review activity for Journal of pharmaceutical & biomedical analysis. (1)
Review activity for Journal of proteome research. (3)
Review activity for Journal of the American Society for Mass Spectrometry. (1)
Review activity for Journal of translational medicine. (1)
Review activity for Metabolomics. (1)
Review activity for Metabolomics. (3)
Review activity for Nature (4)
Review activity for Nature communications (3)
Review activity for Nature medicine. (1)
Review activity for Nature metabolism. (4)
Review activity for Nature protocols (1)
Review activity for Progress in lipid research. (2)
Review activity for Rapid communications in mass spectrometry : (2)
Review activity for STAR protocols. (2)
Review activity for The FASEB journal : (5)